Back

Epidemiology Of Levodopa-Induced Dyskinesia: Prevalence And Associated Clinical Factors In Latin America

2025-08-27 neurology Title + abstract only
View on medRxiv
Show abstract

BackgroundAlthough levodopa remains the gold standard treatment for Parkinsons disease (PD), its chronic use is associated with levodopa-induced dyskinesia (LID), a motor complication that impacts prognosis, quality of life, and treatment costs. Most known LID-associated factors have been identified in European-descendant populations. ObjectivesTo describe the epidemiology of LID in Latin American and Caribbean (LATAM) countries and assess the relevance of known and novel LID-associated factors...

Predicted journal destinations